The Potential of Campanula takesimana Callus Extract to Enhance Skin Barrier Function
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417333 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Boram Mok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, CHA University School of Medicine, CHA University, Seongnam 13488, Republic of Korea. Hauptthemen laut MEDLINE: Skin, Dermatitis, Atopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Ministry of Trade, Industry and Energy, Republic of Korea, Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a prevalent inflammatory skin disease characterized by epidermal barrier dysfunction and Th2-skewed inflammation. Campanula takesimana (C. takesimana), a Korean endemic plant grown on Ulleng Island, has long been associated with a traditional alternative medicine for asthma, tonsillitis, and sore throat. In this study, we reported the effect of C. takesimana callus extract on upregulating epidermal barrier-related proteins dysregulated by Th2 cytokines. C. takesimana callus extract induced the expression of skin barrier proteins, such as filaggrin, claudin-1, and zonula occludens-1, in both human primary keratinocytes and Th2-induced AD-like skin-equivalent models. Additionally, RNA sequencing analysis demonstrated that C. takesimana callus extract partially restored Th2 cytokine-induced dysregulation of the epidermal development and lipid metabolic pathways. Considering the advantages of callus as a sustainable eco-friendly source of bioactive substances, and its effect on skin barrier proteins and lipid metabolic pathways, C. takesimana callus extracts can possibly be utilized to improve the integrity of the skin barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, CHA University School of Medicine, CHA University, Seongnam 13488, Republic of Korea.
- Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Republic of Korea.
- Department of Dermatology, Bundang CHA Medical Center, School of Medicine, CHA University, Seongnam 13496, Republic of Korea.
- Plant Cell Research Institute of BIO-FD&C Co., Ltd., Incheon 21990, Republic of Korea.
ORCID-Profile: Sujin Moon, Yun Kyung Jang, Sung Joo Jang, Sang Hyun Moh, Dong Hyun Kim
Förderung
- Ministry of Health & Welfare, Republic of Korea
- Ministry of Trade, Industry and Energy, Republic of Korea
- Ministry of Health & Welfare, Republic of Korea
- Ministry of Trade, Industry, and Energy (MOTIE, Korea)
Zitieren
APA
Mok, B., Jang, Y. S., Moon, J. H., Moon, S., Jang, Y. K., Kim, S. Y., Jang, S. J., Moh, S. H., Kim, D. H., & Shin, J. U. (2023). The Potential of Campanula takesimana Callus Extract to Enhance Skin Barrier Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417333
Vancouver
Mok B, Jang YS, Moon JH, Moon S, Jang YK, Kim SY, et al. The Potential of Campanula takesimana Callus Extract to Enhance Skin Barrier Function. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417333
BibTeX
@article{Mok2023,
author = {Mok, Boram and Jang, Young Su and Moon, Ji Hwan and Moon, Sujin and Jang, Yun Kyung and Kim, Soo Yun and Jang, Sung Joo and Moh, Sang Hyun and Kim, Dong Hyun and Shin, Jung U},
title = {The Potential of Campanula takesimana Callus Extract to Enhance Skin Barrier Function},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417333}
}
EUVIMED